RecruitingPhase 2NCT06671054
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
Sponsor: SynAct Pharma Aps
Cutler Bay, FL · Miami, FL · +1 more sites